Edward Scolnick

Last updated
Edward Scolnick
Alma mater
Known for Discovery of RAS pathway
Scientific career
Institutions

Edward Scolnick is a core investigator at the Broad Institute, the former founding director of the Stanley Center for Psychiatric Research at Broad Institute, and former head of research and development at Merck Research Laboratories.

Education and career

Scolnick earned a BA in 1961 from Harvard University and an MD in 1965 from Harvard Medical School. [1] After medical school, he joined the Public Health Service to avoid being drafted into the Vietnam War. [2]

During his 15 years at the NIH's National Cancer Institute, Scolnick discovered the RAS oncogene that is involved in the critical signaling pathway that shifts an otherwise normal cell into the aggressive cells known as tumor cells. His work helped establish the concept of blocking signaling pathways as fundamental to cancer biology and drug discovery.[ citation needed ]

Scolnick joined Merck in 1982 as executive director of virus and cell biology, after being recruited from the National Institutes of Health. He was head of Research at Merck Research Laboratories from 1985 until he stepped down in 2002. [3] While at Merck, he was involved in the development and introduction of 29 new medications and vaccines. [4]

He was a key figure in the development and marketing of Vioxx, which was pulled from the market after it was discovered that the drug caused a dangerously high risk of myocardial infarction. [4] Legal claims resulting from this have cost Merck billions. During the five years it was available in the US, more than 38,000 deaths were related to Vioxx use, and up to 25 million Americans took the drug. [5] In the subsequent investigations, it was revealed that it was likely that Merck knew about the adverse effects of the drug, and Scolnick had dismissed them in order to push the drug to market before Bayer's Celebrex. [6] [7]

Scolnick began as the founding director of the Stanley Center for Psychiatric Research at Broad Institute in 2007. In 2012, he stepped down as director and became the Stanley Center's chief scientist, being succeeded by Steven Hyman.

In 1980 he received the Eli Lilly and Company-Elanco Research Award from the American Society for Microbiology. He is an elected member of the National Academy of Sciences and its Institute of Medicine, and the American Academy of Arts and Sciences. He was also appointed to the Board of Visitors at the University of Pittsburgh School of Medicine.

MIT awards the Edward M. Scolnick Prize in Neuroscience in his honor. [8]

Related Research Articles

<span class="mw-page-title-main">David Baltimore</span> American biologist (born 1938)

David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is President Emeritus and Distinguished Professor of Biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He also served as the director of the Joint Center for Translational Medicine, which joined Caltech and UCLA in a program to translate basic scientific discoveries into clinical realities. He also formerly served as president of Rockefeller University from 1990 to 1991, founder and director of the Whitehead Institute of Biomedical Research from 1982 to 1990, and was president of the American Association for the Advancement of Science in 2007.

<span class="mw-page-title-main">Whitehead Institute</span> Non-profit biomedical research institute

<span class="mw-page-title-main">Cold Spring Harbor Laboratory</span> Private, non-profit research institution in New York, United States

Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, plant biology, genomics, and quantitative biology.

The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research.

<span class="mw-page-title-main">Harold E. Varmus</span> American scientist (born 1939)

Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

<span class="mw-page-title-main">Broad Institute</span> Biomedical and genomic research center

The Eli and Edythe L. Broad Institute of MIT and Harvard, often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and it partners with the Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

<span class="mw-page-title-main">Erich Jarvis</span>

Erich Jarvis is an American professor at Rockefeller University. He leads a team of researchers who study the neurobiology of vocal learning, a critical behavioral substrate for spoken language. The animal models he studies include songbirds, parrots, and hummingbirds. Like humans, these bird groups have the ability to learn new sounds and pass on their vocal repertoires culturally, from one generation to the next. Jarvis focuses on the molecular pathways involved in the perception and production of learned vocalizations, and the development of brain circuits for vocal learning.

Steven Edward Hyman is Director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts. He is also Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Hyman was Provost of Harvard University from 2001 to 2011 and before that Director of the U.S. National Institute of Mental Health (NIMH) from 1996 to 2001. Hyman received the 2016 Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine for "leadership in furthering understanding and treatment of psychiatric disorders as biological diseases".

<span class="mw-page-title-main">Peter S. Kim</span> American scientist

Peter S. Kim is an American scientist. He was president of Merck Research Laboratories (MRL) 2003–2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.

Richard Lewis Huganir is a Bloomberg Distinguished Professor in the Departments of Neuroscience and Psychological and Brain Sciences, Director of the Solomon H. Snyder Department of Neuroscience, and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences in the Johns Hopkins School of Medicine.

<span class="mw-page-title-main">Thomas R. Insel</span> American neuroscientist

Thomas Roland Insel is an American neuroscientist, psychiatrist, entrepreneur, and author who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia. He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment. He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X. On May 8, 2017, CNBC reported that he had left Verily Life Sciences. Insel is a Co-founder with Richard Klausner and Paul Dagum of a digital mental health company named "Mindstrong," a Bay-area startup. He has also co-founded Humanest Care, NeuraWell Therapeutics, and MindSite News and is a member of the scientific advisory board for Compass Pathways, a company that is developing the psychedelic drug psilocybin to treat depression and other mental health disorders. His book, Healing: Our Path from Mental Illness to Mental Health was published by Penguin Random House in February, 2022.

Utpal Banerjee is a distinguished professor of the department of molecular, cell and developmental biology at UCLA. He obtained his Bachelor of Science degree in chemistry from St. Stephen's College, Delhi University, India and obtained his Master of Science degree in physical chemistry from the Indian Institute of Technology, Kanpur, India. In 1984, he obtained a PhD in chemistry from the California Institute of Technology where he was also a postdoctoral Fellow in the laboratory of Seymour Benzer from 1984-1988.

Haim Aviv was an Israeli scientist who specialized in the field of molecular biology. Aviv is considered to have a fundamental role in the shaping of the biotechnology industry in Israel, as he was widely involved in this industry since the late 1970s to this day.

The White House BRAIN Initiative is a collaborative, public-private research initiative announced by the Obama administration on April 2, 2013, with the goal of supporting the development and application of innovative technologies that can create a dynamic understanding of brain function.

<span class="mw-page-title-main">Peng Loh</span> American biochemist

Yoke Peng Loh is an American biochemist and molecular biologist currently acting as Senior Investigator and Head at the Section on Cellular Neurobiology, Laboratory of Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). She earned a B.S. in biochemistry at University College Dublin in 1969 and a Ph.D. from the University of Pennsylvania in 1973. She did her postdoctoral work with Harold Gainer at NIH and at the Max Planck Institute in Germany.

The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease.

<span class="mw-page-title-main">Judith L. Rapoport</span> American psychiatrist

Judith L. Rapoport is an American psychiatrist. She is the chief of the Child Psychiatry Branch at the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH) in Bethesda, Maryland.

<span class="mw-page-title-main">Daniel Colón-Ramos</span> Researcher, Yale University School of Medicine

Daniel Alfonso Colón-Ramos is the McConnell Duberg Professor of Neuroscience and Cell Biology at Yale University School of Medicine, where his lab studies the cell biology of the synapse during development and learning. He is also the founder of the nonprofit organization Ciencia Puerto Rico (CienciaPR), a collaborative network for people interested in science and Puerto Rico. In 2020, he was named to the National Academy of Medicine.

Joshua R Sanes is an American neurobiologist who is known for his contributions to the understanding of synapse development. Throughout his career, Sanes has been the recipient of various awards and honors, including membership to the U.S. National Academy of Sciences. His research involves an interdisciplinary approach which focuses mainly on the formation of synapses at the neuromuscular junction by combining the sciences of psychology, chemistry, biology, and engineering to study these circuits and employ molecular and genetic imaging to understand their function. Sanes currently lives in Boston, Massachusetts with his wife, Susan, and their two children.

<span class="mw-page-title-main">Marisela Morales (neuroscientist)</span> Mexican neuroscientist

Marisela Morales is a Mexican neuroscientist specializing in the neurobiology of drug addiction. She is a senior investigator at the National Institute on Drug Abuse.

References

  1. ↑ "Boston and San Francisco based Health Care and Life Science Investment Firm - Clarus". www.clarusfunds.com.
  2. ↑ "NCI Oral History Project, Interview with Edward Scolnick, M.D." (PDF). history.nih.gov. June 24, 1998. Retrieved 2017-05-19.
  3. ↑ "Edward M. Scolnick, M.D., Steps Down as President of Merck Research Laboratories and Member of Board of Directors, Returns to Laboratories - Evaluate". www.evaluategroup.com.
  4. 1 2 "Will Merck Survive Vioxx? - November 1, 2004". archive.fortune.com.
  5. ↑ "Vioxx - Uses, Side Effects, History and Market Withdrawal".
  6. ↑ "Merck's Fall from Grace - The Scientist Magazine®". The Scientist.
  7. ↑ Bowe, Christopher (20 June 2005). "Scolnick: retired but far from retiring" – via Financial Times.
  8. ↑ "Edward M. Scolnick Prize in Neuroscience - McGovern Institute for Brain Research at MIT". mcgovern.mit.edu.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.